SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-06-21 08:56
Tx date 2024-06-17
$RPTX
Repare Therapeutics Inc.
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$103,360
+27,200 vol
$3.80 each
195,333
Filed 2023-06-12 09:43
Tx date 2023-06-08
$RPTX
Repare Therapeutics Inc.
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$317,152
+27,200 vol
$11.66 each
168,133
Filed 2023-06-09 16:05
Tx date 2023-06-08
$RPTX
Repare Therapeutics Inc.
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$317,152
+27,200 vol
$11.66 each
Filed 2023-06-09 16:05
Tx date 2023-06-08
$RPTX
Repare Therapeutics Inc.
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$317,152
+27,200 vol
$11.66 each
168,133
Filed 2022-05-16 14:42
Tx date 2022-05-13
$RPTX
Repare Therapeutics Inc.
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$467,950
+49,000 vol
$9.55 each
140,933
Filed 2021-05-17 16:14
Tx date 2021-05-13
$RPTX
Repare Therapeutics Inc.
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$681,240
+21,000 vol
$32.44 each
91,933
Filed 2021-05-14 13:18
Tx date 2021-05-13
$RPTX
Repare Therapeutics Inc.
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$681,240
+21,000 vol
$32.44 each
Filed 2021-05-14 13:18
Tx date 2021-05-13
$RPTX
Repare Therapeutics Inc.
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$681,240
+21,000 vol
$32.44 each
91,933
Filed 2020-07-02 19:52
Tx date 2020-06-22
$RPTX
Repare Therapeutics Inc.
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
70,933